<SEC-DOCUMENT>0001965301-23-000086.txt : 20230801
<SEC-HEADER>0001965301-23-000086.hdr.sgml : 20230801
<ACCEPTANCE-DATETIME>20230801165009
ACCESSION NUMBER:		0001965301-23-000086
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20230801
DATE AS OF CHANGE:		20230801

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Roivant Sciences Ltd.
		CENTRAL INDEX KEY:			0001635088
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				981173944
		STATE OF INCORPORATION:			D0
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-40782
		FILM NUMBER:		231132488

	BUSINESS ADDRESS:	
		STREET 1:		CLARENDON HOUSE, 2 CHURCH STREET
		CITY:			HAMILTON HM11
		STATE:			D0
		ZIP:			HM11
		BUSINESS PHONE:		441-295-5950

	MAIL ADDRESS:	
		STREET 1:		CLARENDON HOUSE
		STREET 2:		2 CHURCH STREET
		CITY:			HAMILTON
		STATE:			D0
		ZIP:			HM11

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Kumar Rakhi
		CENTRAL INDEX KEY:			0001856296

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		C/O NEUROPACE INC
		STREET 2:		455 N BERNARDO AVENUE
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001856296</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001635088</issuerCik>
      <issuerName>Roivant Sciences Ltd.</issuerName>
      <secFileNumber>001-40782</secFileNumber>
      <issuerAddress>
        <com:street1>CLARENDON HOUSE, 2 CHURCH STREET</com:street1>
        <com:city>HAMILTON HM11</com:city>
        <com:stateOrCountry>D0</com:stateOrCountry>
        <com:zipCode>HM11</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>441-295-5950</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Kumar Rakhi</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Rockefeller Financial LLC</name>
        <address>
          <com:street1>45 Rockefeller Plaza</com:street1>
          <com:street2>Floor 5</com:street2>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10111</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>336</noOfUnitsSold>
      <aggregateMarketValue>4032.00</aggregateMarketValue>
      <noOfUnitsOutstanding>766811433</noOfUnitsOutstanding>
      <approxSaleDate>08/01/2023</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Shares</securitiesClassTitle>
      <acquiredDate>08/01/2023</acquiredDate>
      <natureOfAcquisitionTransaction>Options Exercise- Grant Date- 5/22/2017</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Roivant Sciences Ltd</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>336</amountOfSecuritiesAcquired>
      <paymentDate>08/01/2023</paymentDate>
      <natureOfPayment>Wire</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Rakhi Kumar c/o Roivant Sciences Ltd.</name>
        <address>
          <com:street1>7th Floor 50 broadway</com:street1>
          <com:city>london</com:city>
          <com:stateOrCountry>X0</com:stateOrCountry>
          <com:zipCode>SW1H0DB</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Shares</securitiesClassTitle>
      <saleDate>05/01/2023</saleDate>
      <amountOfSecuritiesSold>62219</amountOfSecuritiesSold>
      <grossProceeds>533974.37</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Rakhi Kumar c/o Roivant Sciences Ltd.</name>
        <address>
          <com:street1>7th Floor 50 broadway</com:street1>
          <com:city>london</com:city>
          <com:stateOrCountry>X0</com:stateOrCountry>
          <com:zipCode>SW1H0DB</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Shares</securitiesClassTitle>
      <saleDate>05/02/2023</saleDate>
      <amountOfSecuritiesSold>15517</amountOfSecuritiesSold>
      <grossProceeds>130685.55</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Rakhi Kumar c/o Roivant Sciences Ltd.</name>
        <address>
          <com:street1>7th Floor 50 broadway</com:street1>
          <com:city>london</com:city>
          <com:stateOrCountry>X0</com:stateOrCountry>
          <com:zipCode>SW1H0DB</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Shares</securitiesClassTitle>
      <saleDate>05/23/2023</saleDate>
      <amountOfSecuritiesSold>1557</amountOfSecuritiesSold>
      <grossProceeds>14916.06</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Rakhi Kumar c/o Roivant Sciences Ltd.</name>
        <address>
          <com:street1>7th Floor 50 broadway</com:street1>
          <com:city>london</com:city>
          <com:stateOrCountry>X0</com:stateOrCountry>
          <com:zipCode>SW1H0DB</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Shares</securitiesClassTitle>
      <saleDate>06/09/2023</saleDate>
      <amountOfSecuritiesSold>43893</amountOfSecuritiesSold>
      <grossProceeds>435726.62</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Rakhi Kumar c/o Roivant Sciences Ltd.</name>
        <address>
          <com:street1>7th Floor 50 broadway</com:street1>
          <com:city>london</com:city>
          <com:stateOrCountry>X0</com:stateOrCountry>
          <com:zipCode>SW1H0DB</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Shares</securitiesClassTitle>
      <saleDate>06/22/2023</saleDate>
      <amountOfSecuritiesSold>1357</amountOfSecuritiesSold>
      <grossProceeds>13583.57</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Rakhi Kumar c/o Roivant Sciences Ltd.</name>
        <address>
          <com:street1>7th Floor 50 broadway</com:street1>
          <com:city>london</com:city>
          <com:stateOrCountry>X0</com:stateOrCountry>
          <com:zipCode>SW1H0DB</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Shares</securitiesClassTitle>
      <saleDate>07/14/2023</saleDate>
      <amountOfSecuritiesSold>535</amountOfSecuritiesSold>
      <grossProceeds>6420.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Rakhi Kumar c/o Roivant Sciences Ltd.</name>
        <address>
          <com:street1>7th Floor 50 broadway</com:street1>
          <com:city>london</com:city>
          <com:stateOrCountry>X0</com:stateOrCountry>
          <com:zipCode>SW1H0DB</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Shares</securitiesClassTitle>
      <saleDate>07/18/2023</saleDate>
      <amountOfSecuritiesSold>100</amountOfSecuritiesSold>
      <grossProceeds>1200.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Rakhi Kumar c/o Roivant Sciences Ltd.</name>
        <address>
          <com:street1>7th Floor 50 broadway</com:street1>
          <com:city>london</com:city>
          <com:stateOrCountry>X0</com:stateOrCountry>
          <com:zipCode>SW1H0DB</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Shares</securitiesClassTitle>
      <saleDate>07/24/2023</saleDate>
      <amountOfSecuritiesSold>1393</amountOfSecuritiesSold>
      <grossProceeds>15309.07</grossProceeds>
    </securitiesSoldInPast3Months>
    <remarks>The shares reported on this Form 144 will be sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 02/25/2023.</remarks>
    <noticeSignature>
      <noticeDate>08/01/2023</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>02/25/2023</planAdoptionDate>
      </planAdoptionDates>
      <signature>/s/ Christian Nasser, as a duly authorized representative of National Financial Services LLC, as attorney-in-fact for Rakhi Kumar</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
